Work

REMOVED: Allogeneic Transplantation for High Risk Chronic Granulomatous Disease Patients.

Year: 2025

Type: article

Abstract: This abstract has been removed: please see Elsevier policy on article withdrawal (https://www.elsevier.com/about/policies-and-standards/article-withdrawal). This article has been removed at the request of the author. This abstract has been removed because it was not presented at the 2025 BMT Tandem Meeting.

Source: Transplantation and Cellular Therapy

DOI: 10.1016/j.jtct.2025.01.489

Authors: Elizabeth M. Kang, Julie Serio, Sandra Maxwell, Sandra Anaya O'Brien, Harry L. Malech

Institutions: National Institutes of Health, National Institute of Allergy and Infectious Diseases

Language: English

Topic: Immunodeficiency and Autoimmune Disorders

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,650